HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

PeopleandPicks.com is Zacks' Community Website
Find great stocks and great stock pickers in our online community. It's social, it's profitable and it's Free! Join the fun at PeopleandPicks.com
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


SNY: Sanofi Aventis - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
SANOFI AVENTIS (NYSE)
SNY 37.67 -0.01 (-0.03%) Vol.  1,097,541 16.00 CST

Nov 19, 2009 New GoMeals(TM) iPhone Application from sanofi-aventis U.S. to Help People with Diabetes Eat Healthy Anywhere, Anytime
Nov 16, 2009 Zacks Analyst Blog Highlights: GlaxoSmithKline plc, Sanofi-Aventis, Novartis, Baxter International and AstraZeneca
Nov 16, 2009 Sanofi-aventis Launches Major New Registry Including Over 10,000 Patients Worldwide With Atrial Fibrillation
Nov 16, 2009 Sanofi Aventis (SNY) Trading In Tight Support/Resistance Range
Nov 11, 2009 Video: Sanofi Pasteur Announces Final Results of U.S. Clinical Trials of Influenza A (H1N1) Vaccine in Adults and Children
Nov 11, 2009 Sanofi-Aventis, Regeneron Expand Partnership
Nov 10, 2009 Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
Nov 05, 2009 Sanofi Aventis (SNY) Trading In Tight Support/Resistance Range
Nov 02, 2009 Sanofi Pasteur Presents Safety Data on Menactra(R) Vaccine Given to Infants at Infectious Disease Society Meeting
Oct 31, 2009 Sanofi-Aventis looks to expand vaccine business (SNY)
Oct 30, 2009 Sanofi-Aventis Reports Profit, Raises Guidance Based on H1N1 Vaccine - Shares Rose Initially in European Trading But Begin US Pre-Market Under Water
Oct 30, 2009 Sanofi-aventis Video Q&A: CEO Chris Viehbacher Comments on Q3 '09 Earning and Outlook
Oct 29, 2009 MITI: Collaboration and License Agreement w/Sanofi-Aventis for BiTE(R) Antibody
Oct 29, 2009 Micromet and Sanofi-aventis Sign Global Collaboration and License Agreement for New Solid Tumor BiTE Antibody
Oct 27, 2009 Sanofi-Aventis Up 20.8% Since SmarTrend's Buy Recommendation
 
ZACKS COMMENTARY FOR SNY
Nov 20, 2009 Zacks Blog: Pozen Initiates New Phase III
Nov 20, 2009 Zacks Blog: AstraZeneca Seeks FDA Approval
Nov 16, 2009 Zacks Blog: Zacks Analyst Blog Highlights: GlaxoSmithKline plc, Sanofi-Aventis, Novartis, Baxter International and AstraZeneca
Nov 13, 2009 Zacks Blog: Glaxo H1N1 Vaccine Approved
Nov 10, 2009 Industry Outlook: Big Pharma & Biotech
Nov 10, 2009 Zacks Analyst Interviews: Big Pharma & Biotech
Nov 09, 2009 Zacks Blog: Lower Q3 Loss for Regeneron
Nov 09, 2009 Zacks Blog: Big Pharma and Biotech
Nov 09, 2009 Zacks Blog: Micromet Misses Estimates
Oct 30, 2009 Zacks Blog: Approval for Merck-SGP Merger
Oct 26, 2009 Zacks Blog: Zacks Analyst Blog Highlights: Schering-Plough, Merck & Co., Sanofi-Aventis, Google and eBay
Oct 23, 2009 Zacks Blog: EU Nod for Merck-Schering Merger

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research